• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?

作者信息

Hasselbalch Hans C

机构信息

Department of Hematology, Zealand University Hospital, Roskilde, Denmark.

出版信息

Hemasphere. 2020 Jun 8;4(3):e407. doi: 10.1097/HS9.0000000000000407. eCollection 2020 Jun.

DOI:10.1097/HS9.0000000000000407
PMID:32647805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7306306/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0b/7306306/aac06588fd80/hs9-4-e407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0b/7306306/aac06588fd80/hs9-4-e407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf0b/7306306/aac06588fd80/hs9-4-e407-g001.jpg

相似文献

1
Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?细胞因子谱分析作为预测骨髓增殖性肿瘤预后的一种新型补充工具？
Hemasphere. 2020 Jun 8;4(3):e407. doi: 10.1097/HS9.0000000000000407. eCollection 2020 Jun.
2
Correction Notice: Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?更正通知：细胞因子谱分析作为预测骨髓增殖性肿瘤预后的一种新型辅助工具？
Hemasphere. 2020 Aug 21;4(5):e482. doi: 10.1097/HS9.0000000000000482. eCollection 2020 Oct.
3
Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis.分子谱分析作为预测骨髓增殖性肿瘤对α-干扰素2反应的新工具：早期骨髓纤维化的概念验证
Cancer. 2017 Jul 15;123(14):2600-2603. doi: 10.1002/cncr.30676. Epub 2017 May 18.
4
Clinical Exome Sequencing unravels new disease-causing mutations in the myeloproliferative neoplasms: A pilot study in patients from the state of Qatar.临床外显子组测序揭示骨髓增殖性肿瘤中的新致病突变：来自卡塔尔的患者的一项试点研究。
Gene. 2019 Mar 20;689:34-42. doi: 10.1016/j.gene.2018.12.009. Epub 2018 Dec 13.
5
Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation.骨髓增殖性肿瘤（MPN）患者和视网膜玻璃膜疣表现出补体系统失调的迹象以及高度的慢性低度炎症。
EClinicalMedicine. 2021 Dec 25;43:101248. doi: 10.1016/j.eclinm.2021.101248. eCollection 2022 Jan.
6
Diagnosis- and Prognosis-Related Gene Alterations in -Negative Myeloproliferative Neoplasms.- 阴性骨髓增殖性肿瘤中的诊断和预后相关基因改变。
Int J Mol Sci. 2023 Aug 21;24(16):13008. doi: 10.3390/ijms241613008.
7
JAK2 inhibitors in the treatment of myeloproliferative neoplasms.JAK2 抑制剂在骨髓增殖性肿瘤治疗中的应用。
Expert Opin Investig Drugs. 2012 Dec;21(12):1755-74. doi: 10.1517/13543784.2012.721352. Epub 2012 Sep 19.
8
Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs).骨髓增殖性肿瘤（MPN）中的钙网蛋白（CALR）突变
Stem Cell Investig. 2015 Aug 31;2:16. doi: 10.3978/j.issn.2306-9759.2015.08.01. eCollection 2015.
9
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis.在费城染色体阴性骨髓增殖性肿瘤中，IRF4表达水平较低，且与较差的预后相关。
Exp Hematol Oncol. 2021 Dec 24;10(1):58. doi: 10.1186/s40164-021-00253-y.
10
Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisions.骨髓增殖性肿瘤中的突变：预后意义、生物学窗口及对治疗决策的影响
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):552-560. doi: 10.1182/asheducation-2016.1.552.

引用本文的文献

1
Mutations, inflammation and phenotype of myeloproliferative neoplasms.骨髓增殖性肿瘤的突变、炎症与表型
Front Oncol. 2023 May 22;13:1196817. doi: 10.3389/fonc.2023.1196817. eCollection 2023.
2
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment.真性红细胞增多症患者的肠道微生物群与健康对照者不同，且因治疗而异。
Blood Adv. 2023 Jul 11;7(13):3326-3337. doi: 10.1182/bloodadvances.2022008555.
3
Potential of Immunotherapies in Treating Hematological Cancer-Infection Comorbidities-A Mathematical Modelling Approach.

本文引用的文献

1
Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia.纵向细胞因子分析确定GRO-α和表皮生长因子为原发性血小板增多症疾病进展的潜在生物标志物。
Hemasphere. 2020 May 21;4(3):e371. doi: 10.1097/HS9.0000000000000371. eCollection 2020 Jun.
2
Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients.羟基脲改变镰状细胞贫血患者循环单核细胞亚群，并抑制其炎症潜能。
Sci Rep. 2019 Oct 15;9(1):14829. doi: 10.1038/s41598-019-51339-x.
3
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host.
免疫疗法在治疗血液系统癌症合并感染中的潜力——一种数学建模方法
Cancers (Basel). 2021 Jul 27;13(15):3789. doi: 10.3390/cancers13153789.
4
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon.COVID-19 作为干扰素缺乏和炎症过度活跃的中介：联合使用 JAK1/2 抑制剂与干扰素的原理。
Cytokine Growth Factor Rev. 2021 Aug;60:28-45. doi: 10.1016/j.cytogfr.2021.03.006. Epub 2021 Apr 14.
5
Gene Expression of (GRO-α) and by Platelets in Myeloproliferative Neoplasms.骨髓增殖性肿瘤中血小板对（生长调节致癌基因α）和（此处原文缺失另一基因名称）的基因表达
Hemasphere. 2020 Oct 26;4(6):e490. doi: 10.1097/HS9.0000000000000490. eCollection 2020 Dec.
6
Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR-ABL-Negative Myeloproliferative Neoplasm.BCR-ABL阴性骨髓增殖性肿瘤中炎症、氧化应激与基因组改变之间的协同串扰
Antioxidants (Basel). 2020 Oct 23;9(11):1037. doi: 10.3390/antiox9111037.
7
Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants.骨髓增殖性肿瘤中的细胞因子谱分析：表型相关性、预后预测及遗传变异的作用概述。
Cells. 2020 Sep 21;9(9):2136. doi: 10.3390/cells9092136.
微生物信号驱动 Tet2 缺陷宿主的白血病前期骨髓增生。
Nature. 2018 May;557(7706):580-584. doi: 10.1038/s41586-018-0125-z. Epub 2018 May 16.
4
The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies.炎症在髓系恶性肿瘤发病机制及进展中的关键作用
Cancers (Basel). 2018 Apr 3;10(4):104. doi: 10.3390/cancers10040104.
5
Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI-TLR Cross-Talk.血清IgA免疫复合物通过FcαRI-TLR串扰促进人巨噬细胞、单核细胞和库普弗细胞产生促炎细胞因子。
J Immunol. 2017 Dec 15;199(12):4124-4131. doi: 10.4049/jimmunol.1700883. Epub 2017 Nov 8.
6
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.数学建模作为骨髓增殖性肿瘤作为癌症发展的人类炎症模型的概念验证。
PLoS One. 2017 Aug 31;12(8):e0183620. doi: 10.1371/journal.pone.0183620. eCollection 2017.
7
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.骨髓增殖性肿瘤与炎症：靶向恶性克隆还是炎症过程，或者两者兼而有之。
Leukemia. 2016 May;30(5):1018-24. doi: 10.1038/leu.2016.12. Epub 2016 Feb 8.
8
Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art.骨髓增殖性肿瘤中的炎症介质：最新进展
Mediators Inflamm. 2015;2015:964613. doi: 10.1155/2015/964613. Epub 2015 Nov 23.
9
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.骨髓增殖性肿瘤作为炎症性疾病：证据、后果及展望
Mediators Inflamm. 2015;2015:102476. doi: 10.1155/2015/102476. Epub 2015 Oct 28.
10
Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation.骨髓增殖性肿瘤的发病机制：慢性炎症的作用及机制
Mediators Inflamm. 2015;2015:145293. doi: 10.1155/2015/145293. Epub 2015 Oct 11.